The 2012 Standards of Medical Care in Diabetes provide guidelines for the management of diabetes, emphasizing the importance of ongoing patient education, self-management, and addressing issues beyond glycemic control. These standards aim to guide clinicians, patients, researchers, and payers in diabetes care, with recommendations based on evidence and updated annually by the American Diabetes Association (ADA). The standards include sections on children, pregnant women, and prediabetes, and emphasize the use of evidence-based practices, including screening, diagnosis, and treatment. The ADA uses a grading system to classify the strength of evidence for each recommendation. The standards also address the diagnosis of diabetes, including the use of A1C and fasting plasma glucose (FPG) tests, and the risks associated with prediabetes. The standards recommend testing for diabetes in asymptomatic individuals, particularly those with risk factors, and emphasize the importance of early detection and prevention of diabetes complications. The standards also provide guidance on the management of gestational diabetes, including screening and follow-up care. The standards emphasize the importance of glycemic control, with A1C targets and recommendations for monitoring and adjusting treatment. The standards also address the prevention and delay of type 2 diabetes through lifestyle interventions and, when appropriate, metformin. The standards highlight the importance of a multidisciplinary approach to diabetes care, including education, monitoring, and management of complications. The standards are revised annually to incorporate new evidence and are reviewed by the ADA's Board of Directors. The standards also address the limitations of A1C testing, including its potential inaccuracies in certain populations and the need for additional testing in cases of suspected hemoglobinopathies. The standards emphasize the importance of individualized care, considering patient preferences, comorbidities, and other factors in setting treatment goals. The standards also highlight the importance of follow-up and monitoring for diabetes complications, including retinopathy, nephropathy, and neuropathy. The standards recommend regular testing for diabetes and prediabetes, with specific guidelines for different populations, including children, pregnant women, and individuals with a history of gestational diabetes. The standards also emphasize the importance of lifestyle interventions, including weight loss, physical activity, and dietary changes, in the prevention and management of diabetes. The standards provide guidance on the use of glucose monitoring, including self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM), and the importance of adjusting treatment based on monitoring results. The standards also address the use of A1C testing, including its limitations and the importance of interpreting results in the context of the patient's clinical situation. The standards emphasize the importance of individualized care, with treatment goals and interventions tailored to the patient's needs and circumstances. The standards also highlight the importance of ongoing education and support for patients with diabetes, including diabetes self-management education (DSME) and ongoing support. The standards provide guidance on the management of diabetes complications, including the prevention and treatment ofThe 2012 Standards of Medical Care in Diabetes provide guidelines for the management of diabetes, emphasizing the importance of ongoing patient education, self-management, and addressing issues beyond glycemic control. These standards aim to guide clinicians, patients, researchers, and payers in diabetes care, with recommendations based on evidence and updated annually by the American Diabetes Association (ADA). The standards include sections on children, pregnant women, and prediabetes, and emphasize the use of evidence-based practices, including screening, diagnosis, and treatment. The ADA uses a grading system to classify the strength of evidence for each recommendation. The standards also address the diagnosis of diabetes, including the use of A1C and fasting plasma glucose (FPG) tests, and the risks associated with prediabetes. The standards recommend testing for diabetes in asymptomatic individuals, particularly those with risk factors, and emphasize the importance of early detection and prevention of diabetes complications. The standards also provide guidance on the management of gestational diabetes, including screening and follow-up care. The standards emphasize the importance of glycemic control, with A1C targets and recommendations for monitoring and adjusting treatment. The standards also address the prevention and delay of type 2 diabetes through lifestyle interventions and, when appropriate, metformin. The standards highlight the importance of a multidisciplinary approach to diabetes care, including education, monitoring, and management of complications. The standards are revised annually to incorporate new evidence and are reviewed by the ADA's Board of Directors. The standards also address the limitations of A1C testing, including its potential inaccuracies in certain populations and the need for additional testing in cases of suspected hemoglobinopathies. The standards emphasize the importance of individualized care, considering patient preferences, comorbidities, and other factors in setting treatment goals. The standards also highlight the importance of follow-up and monitoring for diabetes complications, including retinopathy, nephropathy, and neuropathy. The standards recommend regular testing for diabetes and prediabetes, with specific guidelines for different populations, including children, pregnant women, and individuals with a history of gestational diabetes. The standards also emphasize the importance of lifestyle interventions, including weight loss, physical activity, and dietary changes, in the prevention and management of diabetes. The standards provide guidance on the use of glucose monitoring, including self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM), and the importance of adjusting treatment based on monitoring results. The standards also address the use of A1C testing, including its limitations and the importance of interpreting results in the context of the patient's clinical situation. The standards emphasize the importance of individualized care, with treatment goals and interventions tailored to the patient's needs and circumstances. The standards also highlight the importance of ongoing education and support for patients with diabetes, including diabetes self-management education (DSME) and ongoing support. The standards provide guidance on the management of diabetes complications, including the prevention and treatment of